These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 26405028

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up.
    Mok CC, Ying KY, Yim CW, Siu YP, Tong KH, To CH, Ng WL.
    Ann Rheum Dis; 2016 Jan; 75(1):30-6. PubMed ID: 25550339
    [Abstract] [Full Text] [Related]

  • 5. Outcome of lupus nephritis in childhood onset SLE in North and Central India: single-centre experience over 25 years.
    Srivastava P, Abujam B, Misra R, Lawrence A, Agarwal V, Aggarwal A.
    Lupus; 2016 Apr; 25(5):547-57. PubMed ID: 26637291
    [Abstract] [Full Text] [Related]

  • 6. Remission of proteinuria indicates good prognosis in patients with diffuse proliferative lupus nephritis.
    Koo HS, Kim S, Chin HJ.
    Lupus; 2016 Jan; 25(1):3-11. PubMed ID: 26159540
    [Abstract] [Full Text] [Related]

  • 7. Mycophenolate mofetil versus azathioprine as maintenance therapy for lupus nephritis: a meta-analysis.
    Feng L, Deng J, Huo DM, Wu QY, Liao YH.
    Nephrology (Carlton); 2013 Feb; 18(2):104-10. PubMed ID: 23113811
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Sequential therapies for proliferative lupus nephritis.
    Contreras G, Pardo V, Leclercq B, Lenz O, Tozman E, O'Nan P, Roth D.
    N Engl J Med; 2004 Mar 04; 350(10):971-80. PubMed ID: 14999109
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Combination immunosuppressant therapy and lupus nephritis outcome: a hospital-based study.
    Chen YM, Hung WT, Liao YW, Hsu CY, Hsieh TY, Chen HH, Hsieh CW, Lin CT, Lai KL, Tang KT, Tseng CW, Huang WN, Chen YH.
    Lupus; 2019 Apr 04; 28(5):658-666. PubMed ID: 30971165
    [Abstract] [Full Text] [Related]

  • 12. Long-term outcomes of lupus nephritis treated with regimens based on cyclophosphamide and mycophenolate mofetil.
    Prasad N, Kurian J, Agarwal V, Bhadauria D, Behera M, Yacha M, Kushwaha R, Agrawal V, Jain M, Gupta A.
    Lupus; 2020 Jul 04; 29(8):845-853. PubMed ID: 32437258
    [Abstract] [Full Text] [Related]

  • 13. Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis.
    Mok CC, Ying KY, Tang S, Leung CY, Lee KW, Ng WL, Wong RW, Lau CS.
    Arthritis Rheum; 2004 Aug 04; 50(8):2559-68. PubMed ID: 15334470
    [Abstract] [Full Text] [Related]

  • 14. Mycophenolate mofetil versus azathioprine in the maintenance therapy of lupus nephritis.
    Sahin GM, Sahin S, Kiziltas S, Masatlioglu S, Oguz F, Ergin H.
    Ren Fail; 2008 Aug 04; 30(9):865-9. PubMed ID: 18925525
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Maintenance therapies for proliferative lupus nephritis: mycophenolate mofetil, azathioprine and intravenous cyclophosphamide.
    Contreras G, Tozman E, Nahar N, Metz D.
    Lupus; 2005 Aug 04; 14 Suppl 1():s33-8. PubMed ID: 15803929
    [Abstract] [Full Text] [Related]

  • 17. Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis.
    Chan TM, Tse KC, Tang CS, Mok MY, Li FK, Hong Kong Nephrology Study Group.
    J Am Soc Nephrol; 2005 Apr 04; 16(4):1076-84. PubMed ID: 15728784
    [Abstract] [Full Text] [Related]

  • 18. Longterm Data on Disease Flares in Patients with Proliferative Lupus Nephritis in Recent Years.
    Yap DYH, Tang C, Ma MKM, Mok MMY, Chan GCW, Kwan LPY, Chan TM.
    J Rheumatol; 2017 Sep 04; 44(9):1375-1383. PubMed ID: 28668803
    [Abstract] [Full Text] [Related]

  • 19. Outcome and predictors of renal survival in patients with lupus nephritis: Comparison between cyclophosphamide and mycophenolate mofetil.
    Joo YB, Kang YM, Kim HA, Suh CH, Kim TJ, Park YW, Lee J, Lee JH, Yoo DH, Bae SC, Lee HS, Bang SY.
    Int J Rheum Dis; 2018 May 04; 21(5):1031-1039. PubMed ID: 29611341
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.